Investigators compared oncologic outcomes among patients with tumors in the bladder only vs in the bladder neck/urethra.

In patients with bladder cancer, lactylation score may predict survival and efficacy of immune checkpoint inhibitor treatment, according to researchers.

Lee, Petros Grivas, Robert Montgomery, Jonathan Wright, Hung-Ming Lam, Andrew Hsieh, Gavin Ha. Deciphering heterogeneity and tumor evolution in bladder cancer using multi-omics and liquid biopsies ...

Dr. Matthew Galsky highlights the impact of Imfinzi’s adjuvant approval for patients with muscle-invasive bladder cancer ...

Pfizer Inc. (NYSE: PFE) today announced results from the pivotal Phase 3 CREST trial of sasanlimab, an investigational ...

Dr. Matthew Galsky discusses the FDA approval of Imfinzi and chemo before and after surgery for muscle-invasive bladder ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, will announce new clinical findings for ANKTIVA® ...

The subtypes investigated in bladder cancer were CK19 ... information about the quality of lymph node sample along with tumor burden. Although not uniformly accepted, this index is the most ...

Chris Cotton is raising money for cancer centers after being told the day after his 50th birthday that what he thought was a ...

A dad who thought he had a UTI was diagnosed with stage four bladder cancer and given 24 months to live. Dad-of-two Chris Cotton, 50, started experiencing what he believed were UTI symptoms in October ...